DPP-4 Inhibitors As mentioned above, DPP-4 inhibitors are now an established and successful class of oral anti-hyperglycaemic agents, and are firmly embedded in guidelines for treating T2DM patients without atherosclerotic cardiovascular (CV) disease (116, 117)
Aging and Skin Health As we age, our natural glutathione production declines, which can make the skin more prone to damage from UV exposure and environmental pollutants
Wegovy is a registered trademarks of Novo Nordisk A/S
Semaglutide is administered through a simple, once-weekly semaglutide injection that you can do from the comfort of your home after receiving guidance from our team
FDA Approves Ozempic (Semaglutide) as the Only GLP-1 RA to Reduce the Risk of Worsening Kidney Disease and Cardiovascular Death in Adults With Type 2 Diabetes and Chronic Kidney Disease
Ultraviolet radiations: skin defense-damage mechanism